Pages that link to "Item:Q5122851"
From MaRDI portal
The following pages link to Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts (Q5122851):
Displaying 22 items.
- A prospective combination of phase II and phase III in drug development (Q478229) (← links)
- A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (Q665054) (← links)
- A comparison of methods for constructing confidence intervals after phase II/III clinical trials (Q2874297) (← links)
- Seamlessly Expanding a Randomized Phase II Trial to Phase III (Q3079028) (← links)
- Decision‐theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta‐binomial distribution (Q4634681) (← links)
- Interphase Clinical Trials: Phase III/Phase IV (Q4937306) (← links)
- SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION (Q5066789) (← links)
- Seamless phase II/III/IIIb clinical trial designs with different endpoints for different phases (Q5078036) (← links)
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations (Q5122852) (← links)
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Opportunities and Limitations (Q5122854) (← links)
- Discussion on “Adaptive enrichment designs with a continuous biomarker” by N. Stallard (Q6055892) (← links)
- Blinded sample size recalculation in adaptive enrichment designs (Q6550297) (← links)
- Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments (Q6572271) (← links)
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs (Q6618333) (← links)
- Adding experimental treatment arms to multi-arm multi-stage platform trials in progress (Q6618355) (← links)
- A conditional error function approach for adaptive enrichment designs with continuous endpoints (Q6624677) (← links)
- Point estimation for adaptive trial designs. II: Practical considerations and guidance (Q6625791) (← links)
- Seamless phase 2/3 oncology trial design with flexible sample size determination (Q6627434) (← links)
- Adaptive trial designs in diagnostic accuracy research (Q6627472) (← links)
- Adaptive enrichment trials: what are the benefits? (Q6627920) (← links)
- Statistical tests for two-stage adaptive seamless design using short- and long-term binary outcomes (Q6628538) (← links)
- Adjusting for treatment selection in phase II/III clinical trials with time to event data (Q6629918) (← links)
